Inventor · disambiguated record
Masataka Murakami
Also filed as: MURAKAMI MASATAKA
16 granted patents·5 pending applications·67 citations·filing 2011–2024
91Inventor score
Top patents by PatentIndex Score
21 records- 0195US9878989B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jan 30, 2018·7 cites·2 claims
- 0293US10610520B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Apr 7, 2020·9 cites·12 claims
- 0393US10323026B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jun 18, 2019·20 cites·10 claims
- 0492US10428056B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 1, 2019·4 cites·2 claims
- 0591US11236099B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 1, 2022·4 cites·22 claims
- 0691US10548899B2Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activityTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Feb 4, 2020·7 cites·11 claims
- 0790US10323027B22,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptorTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 18, 2019·4 cites·6 claims
- 0889US10807987B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 20, 2020·5 cites·8 claims
- 0985US10899752B22,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptorTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Jan 26, 2021·1 cites·11 claims
- 1084US11702419B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jul 18, 2023·1 cites·18 claims
- 1182US10208046B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Feb 19, 2019·4 cites·14 claims
- 1280US11274101B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Mar 15, 2022·1 cites·12 claims
- 1378US11834409B2Heterocyclic NMDA antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Dec 5, 2023·0 cites·22 claims
- 1466US12378256B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Aug 5, 2025·0 cites·17 claims
- 1564US2023002318A1Heterocyclic nmda antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 1663US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1762US2024217957A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1849US2022289679A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 1943US2022089525A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 2042US11459325B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 4, 2022·0 cites·10 claims
- 2131US8703758B2Bicyclic compoundYAMASHITA TOHRU·Filed 2011·Granted Apr 22, 2014·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Masataka Murakami files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →